What to Expect When You Volunteer for a COVID-19 Vaccine Study
Before, during, and after the study, we are here to answer any questions you have.
Before You Volunteer for a Clinical Study
When you contact one of the participating research sites, they will tell you about the research we are doing. For some of the monoclonal antibody studies, you will not need to reach out to a site because the study staff will come to the nursing home or assisted living facility.
You may be asked personal questions before coming into the research site to help determine if the studies that are open are a good fit for you.
We will give you and/or your legally authorized representative written information about the study, and you will have a detailed discussion with the study staff to assist in making an informed decision about whether you want to join the study or not.
Most studies require coming into the research site for 10 or more visits over 1-2 years. In some of the monoclonal antibody studies, the study staff will come to you via mobile transportation unit.
If you decide to volunteer for a COVID-19 vaccine or monoclonal antibody study, the study staff will determine if you are eligible to join. This can include things like asking about your medical history and doing a physical exam. Sometimes a blood sample will be drawn for necessary lab tests.
During the Study
Most COVID-19 vaccine or monoclonal antibody studies require coming into the research site for 10 or more visits over 1-2 years.
Every study involves getting injections or infusions. You might get the COVID-19 vaccine or monoclonal antibody we are researching, or you might get a placebo (a liquid with no active ingredients).
When you are enrolled in the study, we will ask you to keep track of how you feel for about a week following each infusion or shot. The study staff will also be in contact with you to find out how you’re feeling during this time.
Volunteers will not be exposed to the coronavirus as part of the study. These are studies of vaccines and monoclonal antibodies designed to prevent COVID-19 that we hope will keep people healthy.
If you become infected with the coronavirus and become ill with COVID-19, the study staff will work with you to make sure you get the care that you need.
Sometimes clinical studies are paused to help ensure the safety of participants. If this happens, the staff will explain the circumstances to you. You will be told about any new information learned from the safety pause.
After the Study
We may ask if we can contact you again for another study.
When the COVID-19 vaccine or monoclonal antibody study is complete, the results will be disseminated to all participants and their communities without any identifying information.
The Importance of Enrolling Diverse Participants in COVID-19 Studies